Magle Chemoswed Holding AB
The answer first
Does Magle Chemoswed Holding beat the market?
No, Magle Chemoswed Holding has not beaten the market over the last year.
Max for seven days
Follow Magle Chemoswed Holding with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 12 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Magle Chemoswed Holding
Your first answer is free, no account needed.
Do you own Magle Chemoswed Holding, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Magle Chemoswed Holding and a few more. Free, no card.
Super Stock+48.4%In short
- Magle Chemoswed Holding has fallen 98.7% over the past year, including dividends.
- The largest fall over the past three years was 99.7%. The price is 99.4% below its peak now.
What do analysts think of Magle Chemoswed Holding?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
- Debt to equityBorrowings divided by equity2.47
- Asset turnoverSales divided by everything the company owns0.36
- Return on equityProfit divided by equity−65.2%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
- P/BPrice divided by equity0.0
- P/SPrice divided by sales0.0
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
- 3 months−46.6%
- 6 months−94.0%
- 9 months−97.7%
- 12 months−98.7%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Magle Chemoswed Holding
One fund we follow owns Magle Chemoswed Holding. The share is how much of the fund the stock makes up.
- Sweden1
From the funds' latest known holdings.
About Magle Chemoswed Holding
Magle Chemoswed Holding AB is a company in healthcare, listed on Nasdaq Stockholm. By market value, Magle Chemoswed Holding is number 123 of 137 companies in healthcare on Nasdaq Stockholm. Magle Chemoswed Holding has not paid a dividend in the past twelve months. The share trades in SEK. It has around 150 employees.
Magle Chemoswed Holding AB (publ) engages in researching, developing, and manufacturing in the areas of medicinal chemistry and pharmaceutical technology in Sweden, Switzerland, rest of Europe, the United States, Brazil, and internationally. It offers degradable starch microsphere and dextran products; and active pharmaceutical ingredients, as well as engages in the research, development, manufacture, market, and sale of diagnostics products to hospitals, clinics, and pharmacies; and contract development and manufacturing organization activities.


See the full analysis of Magle Chemoswed Holding.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card